CIPHER PHARMACEUTICALS INC's ticker is CPHRF and the CUSIP is 17253X105. A total of 17 filers reported holding CIPHER PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,533,000 | +17.6% | 1,941,100 | -7.6% | 1.23% | +3.9% |
| Q1 2017 | $7,256,000 | -5.2% | 2,100,600 | 0.0% | 1.19% | -15.5% |
| Q4 2016 | $7,653,000 | -5.9% | 2,100,600 | -1.6% | 1.40% | -11.5% |
| Q3 2016 | $8,135,000 | -63.2% | 2,134,200 | -51.7% | 1.58% | -30.9% |
| Q2 2016 | $22,082,000 | +104.2% | 4,415,500 | +96.4% | 2.29% | +6.0% |
| Q1 2016 | $10,812,000 | +9.9% | 2,248,400 | +7.3% | 2.16% | +6.8% |
| Q4 2015 | $9,834,000 | +76.7% | 2,095,200 | +39.1% | 2.03% | +63.1% |
| Q3 2015 | $5,566,000 | -42.1% | 1,506,600 | +34.0% | 1.24% | -34.4% |
| Q2 2015 | $9,608,000 | +4208.5% | 1,124,100 | +4451.0% | 1.90% | +3931.9% |
| Q1 2015 | $223,000 | -26.4% | 24,700 | +17.6% | 0.05% | -30.9% |
| Q4 2014 | $303,000 | +13.1% | 21,000 | -35.4% | 0.07% | +17.2% |
| Q2 2014 | $268,000 | – | 32,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Raffles Associates | 447,800 | $1,659,000 | 1.74% |
| Grandeur Peak Global Advisors, LLC | 1,506,600 | $5,566,000 | 1.24% |
| MONTRUSCO BOLTON INVESTMENTS INC. | 1,920,607 | $7,091,000 | 0.61% |
| TAYLOR ASSET MANAGEMENT INC | 526,900 | $1,954,000 | 0.41% |
| ARMISTICE CAPITAL, LLC | 300,000 | $1,115,000 | 0.38% |
| INTACT INVESTMENT MANAGEMENT INC. | 734,900 | $3,601,000 | 0.16% |
| AWM Investment Company, Inc. | 220,000 | $816,000 | 0.16% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 638,000 | $2,356,000 | 0.05% |
| ACADIAN ASSET MANAGEMENT LLC | 739,684 | $2,729,000 | 0.02% |
| EverPoint Asset Management, LLC | 150,000 | $556,000 | 0.01% |